Schiapparelli Lucio, Del Río Joaquín, Frechilla Diana
Division of Neuroscience, Center for Applied Medical Research, School of Medicine, University of Navarra, Pamplona, Spain.
J Neurochem. 2005 Aug;94(4):884-95. doi: 10.1111/j.1471-4159.2005.03193.x.
Stimulation of hippocampal 5-HT(1A) receptors impairs memory retention. The highly selective 5-HT(1A) antagonist, WAY-100635, prevents the cognitive deficits induced not only by 5-HT(1A) stimulation but also by cholinergic or NMDA receptor blockade. On this basis, the effects of WAY-100635 on molecular events associated with memory storage were explored. In rat hippocampus, WAY-100635 produced a rapid increase in phosphorylated Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and in Ca(2+)-independent CaMKII and protein kinase A (PKA) enzyme activity. This increase was followed a few hours later by an enhanced membrane expression of AMPA receptor subunits, especially of the GluR1 subunit phosphorylated at the CaMKII site, pGluR1(Ser831). The same qualitative effects were found with the weaker 5-HT(1A) antagonist NAN-190. The effects of both antagonists were no longer apparent in rats with a previous 5-HT depletion induced by the tryptophan hydroxylase inhibitor p-chlorophenylalanine (PCPA), suggesting that 5-HT(1A) receptor blockade removes the tonic inhibition of 5-HT through 5-HT(1A) receptor stimulation on excitatory hippocampal neurons, with the consequent increase in PKA activity. In addition, administration of WAY-100635 potentiated the learning-specific increase in the hippocampus of phospho-CaMKII, Ca(2+)-independent CaMKII activity, as well as the phosphorylation of either the CaMKII or the PKA site on the AMPA receptor GluR1 subunit. This study suggests that blockade of hippocampal 5-HT(1A) receptors favours molecular events critically involved in memory formation, and provides an in vivo molecular basis for the proposed utility of 5-HT(1A) receptor antagonists in the treatment of cognitive disorders.
海马体5-羟色胺(5-HT)1A受体的刺激会损害记忆保持。高选择性5-HT1A拮抗剂WAY-100635不仅能预防由5-HT1A受体刺激引起的认知缺陷,还能预防由胆碱能或N-甲基-D-天冬氨酸(NMDA)受体阻断引起的认知缺陷。在此基础上,研究了WAY-100635对与记忆存储相关分子事件的影响。在大鼠海马体中,WAY-100635使磷酸化的钙/钙调蛋白依赖性蛋白激酶II(CaMKII)以及非钙依赖性CaMKII和蛋白激酶A(PKA)的酶活性迅速增加。数小时后,这种增加伴随着α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)受体亚基膜表达的增强,尤其是在CaMKII位点(pGluR1(Ser831))磷酸化的GluR1亚基。较弱的5-HT1A拮抗剂NAN-190也有同样的定性效果。在先前由色氨酸羟化酶抑制剂对氯苯丙氨酸(PCPA)诱导5-HT耗竭的大鼠中,两种拮抗剂的作用不再明显,这表明5-HT1A受体阻断消除了5-HT通过5-HT1A受体刺激对海马体兴奋性神经元的紧张性抑制,从而导致PKA活性增加。此外,给予WAY-100635可增强海马体中磷酸化CaMKII、非钙依赖性CaMKII活性以及AMPA受体GluR1亚基上CaMKII或PKA位点磷酸化的学习特异性增加。这项研究表明,阻断海马体5-HT1A受体有利于参与记忆形成的关键分子事件,并为提出的5-HT1A受体拮抗剂在治疗认知障碍中的应用提供了体内分子基础。